SCPX — Scorpius Holdings Share News
0.000.00%
Last trade - 00:00- $0.01m
- $11.13m
- $6.24m
Brief: Heat Biologics Files For Mixed Shelf Of Upto $250 Million
Brief: Heat Biologics Inc Announces Quarterly Loss Per Share $0.06
Heat Biologics: Up on U.S. patent for combination therapy platform
Brief: Heat Biologics Files Prospectus Supplement Relating To Offer & Sale Of Shares Having Offering Price Of Upto $100 Million
Brief: Heat Biologics- Covid-19 Vaccine Demonstrates Robust T Cell Driven Immune Response To Sars-Cov-2 In Preclinical Studies
Heat Biologics: Rises after potential COVID-19 vaccine shows promise in animal testing
Brief: Heat Biologics Posts Quarterly Loss Per Share 5 Cents
Heat Biologics: Surges on positive pre-clinical data from COVID-19 vaccine trial
Brief: Heat Biologics Says Covid-19 Vaccine Demonstrates Immunogenicity Proof-Of-Concept In Pre-Clinical Studies
Brief: Heat Biologics Inc Regains Compliance With Nasdaq Minimum Bid Price Rule
Brief: Heat Biologics Says First Patient Treated In Co's First-In-Human Phase 1 Clinical Trial Evaluating PTX-35
Brief: Heat Biologics Announces FDA Clearance Of Investigational New Drug Application For PTX-35
Brief: Heat Biologics Inc says It Had Cash, Cash Equivalents And Short-Term Investments Of $35.5 Million As Of June 1, 2020
Brief: Heat Biologics Presents Positive Survival Benefit For Hs-110 In Combination With Nivolumab In Phase 2 Lung Cancer Trial At 2020 Asco Annual Meeting
Brief: Heat Biologics Announces Collaboration with Waisman Biomanufacturing to Manufacture COVID-19 Vaccine
Brief: Heat Biologics Plans To Initiate Type B End Of Phase 2 Meeting With FDA To Discuss Registration Strategy For Hs-110
Brief: Heat Biologics Announces Strategy & Anticipated Q2 Milestones For Covid-19 Vaccine Program
Brief: Heat Biologics Terminates Collaboration With University Of Miami For Development Of A Covid-19 Point Of Care Diagnostic
Brief: Heat Biologics Inc Entered Into Amendment To That Certain At Market Issuance Sales Agreement Between Co And B. Riley FBR, Inc.